Aegis Capital Corp. in a $26.4 million Public Offering of Common Stock
Blank Rome represented Aegis Capital Corp. as underwriter, in a $26.4 million public offering of common stock and warrants and “uplisting” of the common stock of Advaxis, Inc., a clinical-stage biotechnology company developing multiple cancer immunotherapies. The transaction closed on October 22, 2013.